tiprankstipranks
TipRanksTop Financial ExpertsInsidersJean Jacques Bienaime

Jean Jacques Bienaime Insider Profile

11 Followers
Jean Jacques Bienaime, Director at Keros Therapeutics, holds 19.59K shares in Keros Therapeutics (Ticker: KROS), holds 2.90K shares in Ascendis Pharma (Ticker: ASND), holds 24.42K shares in Incyte (Ticker: INCY).
See the Hottest Stocks Based on Insider Trading >
tipranks
Jean Jacques Bienaime

Jean Jacques Bienaime
Keros Therapeutics (KROS)
Director

Ranked #8,320 out of 108,921 Corporate Insiders

Profitable Transactions

43%
23 out of 54 Profitable Transactions

Average Return

+8.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$53M
89.93%
5.73%
2.06%
1.44%
0.83% Others
A breakdown of Jean Jacques Bienaime's holdings
See the Top Stocks by Insiders

Insider Roles

BioMarin Pharmaceutical
(BMRN)
Director
Incyte
(INCY)
Director
Immunome
(IMNM)
Director
Ascendis Pharma
(ASND)
Director
+2 other positions
Roles that Jean Jacques Bienaime holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Immunome
(IMNM)
Rating:Informative Buy
Date:Mar 25, 2025 - Mar 25, 2026
Return:+192.00%
The most profitable trade made by Jean Jacques Bienaime
See the Latest Stocks Traded by Insiders

Jean Jacques Bienaime's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KROS
Keros Therapeutics
Aug 19, 2026
Director
Uninformative Buy
10.27K
$218.84K
ASND
Ascendis Pharma
Aug 18, 2026
Director
Informative Buy
492.65K
$757.57K
IMNM
Immunome
Jun 09, 2026
Director
Informative Buy
204.26K
$1.08M
BMRN
BioMarin Pharmaceutical
May 21, 2024
Director
Uninformative Sell
92.61K
$47.25M
IMUX
Immunic
Sep 24, 2018
Director
Informative Sell
7.99K
$219.04K
INCY
Incyte
Jun 10, 2026
Director
Uninformative Buy
―
$3.01M
PTLA
Portola Pharma
May 16, 2014
―
Informative Sell
22.03K
$12.73K
NGSX
Neurogesx
Jul 26, 2011
―
Uninformative Buy
19.18K
$108.74
ITMN
InterMune
―
―
―
―
List of latest transactions for each holding click on a transaction to see Jean Jacques Bienaime's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Jean Jacques Bienaime insider profile FAQ

What is the percentage of profitable transactions made by Jean Jacques Bienaime?
The percentage of profitable transactions made by Jean Jacques Bienaime is 43%.
    What is the average return per transaction made by Jean Jacques Bienaime?
    The average return per transaction made by Jean Jacques Bienaime is 8.90%.
      What stocks does Jean Jacques Bienaime hold?
      Jean Jacques Bienaime holds: KROS, ASND, IMNM, BMRN, IMUX, INCY, PTLA, NGSX, ITMN stocks.
        What was Jean Jacques Bienaime’s latest transaction?
        Jean Jacques Bienaime latest transaction was an Uninformative Buy of $10.27K.
          What was Jean Jacques Bienaime's most profitable transaction?
          Jean Jacques Bienaime’s most profitable transaction was an Informative Buy of IMNM stock on March 25, 2025. The return on the trade was 192.00%.
            What is Jean Jacques Bienaime's role in Keros Therapeutics?
            Jean Jacques Bienaime's role in Keros Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.